Filing Flows › Comparisons › RCUS vs CPIX
Arcus Biosciences vs Cumberland Pharmaceuticals: RCUS and CPIX compared
Arcus Biosciences is the larger company: $9.0M of revenue in its latest quarter (Q3 2026) against $8.8M for Cumberland Pharmaceuticals (Q2 2026). Cumberland Pharmaceuticals is growing faster (-19% against -65% a year earlier).
Where the money goes: RCUS and CPIX
Arcus Biosciences (RCUS) · Q3 2026
Arcus Biosciences, Q3 2026: revenue $9.0M (-65% year over year), net loss $128M, operating cash flow −$88.0M. The chart follows the revenue to costs, profit and cash.
Cumberland Pharmaceuticals (CPIX) · Q2 2026
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
| Arcus Biosciences (RCUS) | Cumberland Pharmaceuticals (CPIX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $9.0M | $8.8M |
| Revenue growth, Y/Y | -65% | -19% |
| Operating margin | n/m | -35.9% |
| Net earnings | −$128M | −$4.3M |
| Net margin | — | -48.6% |
| Operating cash flow | −$88.0M | $169K |
| Free cash flow | — | $130K |
Where the revenue comes from
Arcus Biosciences
- License and development services: $8.0M (89%)
- Other collaboration: $1.0M (11%)
Cumberland Pharmaceuticals
- Talicia: $2.3M (27%)
- Sancuso: $1.8M (21%)
- Vibativ: $1.7M (20%)
- Caldolor: $1.5M (17%)
Questions
Which is bigger, Arcus Biosciences or Cumberland Pharmaceuticals?
Arcus Biosciences is the larger company: $9.0M of revenue in its latest quarter (Q3 2026) against $8.8M for Cumberland Pharmaceuticals (Q2 2026).
Is Arcus Biosciences or Cumberland Pharmaceuticals growing faster?
Cumberland Pharmaceuticals is growing faster (-19% against -65% a year earlier).
More: Arcus Biosciences earnings · how Arcus Biosciences makes money · Cumberland Pharmaceuticals earnings · how Cumberland Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.